Bhatia, Ravi

Chronic myeloid leukemia, version 1.2019, NCCN Clinical Practice Guidelines in Oncology

Radich, J. P., Deininger, M., Abboud, C. N., Altman, J. K., Berman, E., Bhatia, R., Bhatnagar, B., Curtin, P., DeAngelo, D. J., Gotlib, J., et al. (2018) · Journal of the National Comprehensive Cancer Network

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 277

Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment

Chu, S., McDonald, T., Lin, A., Chakraborty, S., Huang, Q., Snyder, D. S., & Bhatia, R. (2011) · Blood

Chronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research

Cited by 245

SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells

Li, L., Osdal, T., Ho, Y., Chun, S., McDonald, T., Agarwal, P., Lin, A., Chu, S., Qi, J., Li, L., et al. (2014) · Cell stem cell

Acute Myeloid Leukemia ResearchSirtuins and Resveratrol in Medicine

Cited by 234

Activation of Stress Response Gene SIRT1 by BCR-ABL Promotes Leukemogenesis

Yuan, H., Wang, Z., Li, L., Zhang, H., Modi, H., Horne, D., Bhatia, R., & Chen, W. (2012) · Blood

Chronic Myeloid Leukemia TreatmentsSirtuins and Resveratrol in Medicine

Cited by 182

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph− acute lymphoblastic leukemia cells

Scuto, A., Kirschbaum, M., Kowolik, C., Kretzner, L., Juhasz, A., Atadja, P., Pullarkat, V., Bhatia, R., Forman, S., Yen, Y., et al. (2008) · Blood

Histone Deacetylase Inhibitors ResearchAcute Lymphoblastic Leukemia research

Cited by 141

The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation

Ha, V. L., Luong, A., Li, F., Casero, D., Malvar, J., Kim, Y. M., Bhatia, R., Crooks, G. M., & Parekh, C. (2017) · Leukemia

Acute Lymphoblastic Leukemia researchT-cell and B-cell Immunology

Cited by 70

Metabolic alterations mediated by STAT3 promotes drug persistence in CML

Patel, S. B., Nemkov, T., Stefanoni, D., Benavides, G. A., Bassal, M. A., Crown, B. L., Matkins, V. R., Camacho, V., Kuznetsova, V., Hoang, A. T., et al. (2021) · Leukemia

Chronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research

Cited by 56

Low c-Kit expression identifies primitive, therapy-resistant CML stem cells

Shah, M., Kumar, H., Qiu, S., Li, H., Harris, M., He, J., Abraham, A., Crossman, D. K., Paterson, A., Welner, R. S., et al. (2023) · JCI Insight

Chronic Myeloid Leukemia TreatmentsHematopoietic Stem Cell Transplantation

Cited by 11